Inside the scientific trial experience with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two patients described anxiety and one particular reported insomnia subsequent abrupt discontinuation within the termination with the scientific trial; in the two sufferers with anxiety, the frequency of cataplexy had improved markedly simultan